SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-20-025063
Filing Date
2020-05-13
Accepted
2020-05-13 16:16:21
Documents
50
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q eq-10q_20200331.htm 10-Q 1730804
2 EX-31.1 eq-ex311_9.htm EX-31.1 15883
3 EX-31.2 eq-ex312_7.htm EX-31.2 15970
4 EX-32.1 eq-ex321_8.htm EX-32.1 7271
  Complete submission text file 0001564590-20-025063.txt   5120805

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT eq-20200331.xml EX-101.INS 993328
6 XBRL TAXONOMY EXTENSION SCHEMA eq-20200331.xsd EX-101.SCH 37427
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE eq-20200331_cal.xml EX-101.CAL 41849
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE eq-20200331_def.xml EX-101.DEF 127140
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE eq-20200331_lab.xml EX-101.LAB 286329
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE eq-20200331_pre.xml EX-101.PRE 214031
Mailing Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037
Business Address 2223 AVENIDA DE LA PLAYA SUITE 105 LA JOLLA CA 92037 (858) 412-5302
Equillium, Inc. (Filer) CIK: 0001746466 (see all company filings)

IRS No.: 821554746 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38692 | Film No.: 20873359
SIC: 2834 Pharmaceutical Preparations